Chief Commercial Officer at eXoZymes, Damien Perriman, states: "We can adjust and be flexible around equipment configuration, but we can’t be flexible around what is a clear communicator and an honest partner."
In the latest PharmaSource podcast episode, Perriman, explains how EXOZ is running its first major CDMO selection process for a platform unlike anything most contract manufacturers have run before, and why the company is weighing communication and cultural fit as heavily as technical capability.
Podcast episode also available on Spotify.